Drugs / DHEA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01256684 | Dec 2010 → Aug 2011 | postmenopausal atrophic vaginitis | EndoCeutics Inc. | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DHEA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01256684 ↗ |
| Route | Other | “daily intravaginal prasterone (6.5 mg)” PMID 25734980 ↗ Sep 2015 |